Accord will be out of stock of phenytoin sodium 100mg capsules until early May 2020.
Phenytoin is classified by the Medicines and Healthcare products Regulatory Agency (MHRA) as a Category 1 anti-epileptic drug; for these drugs, prescribers are advised to ensure that their patient is maintained on a specific manufacturer’s product.
An alternative phenytoin sodium 100mg capsules manufactured by Flynn Pharma is available, however switching to an alternative formulation requires monitoring and may also require specialist support, advice or referral.
This alert contains advice on the management of affected patients.